The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.

Jian Wang, Zhong Chen, Xiaomin Yan, Yue Yang, Yong Liu, Yuxin Chen, Bei Jia, Juan Xia, Yali Xiong, Zhaoping Zhang, Weimao Ding, Rui Huang, Chao WuPubMed 2019

Abstract

eLIFT as a novel index can predict advanced liver fibrosis with a moderate sensitivity and accuracy in CHB patients. eLIFT, though having similar diagnostic values of advanced liver fibrosis compared to more complex existing tools such as APRI, FIB-4, GPR, and RPR in CHB patients, has the advantage of clarity of generation and ease of application and has the potential of being widely used by hepatologists.
BibTeX
@inproceedings{wang2019easy,
  author = {Jian Wang and Zhong Chen and Xiaomin Yan and Yue Yang and Yong Liu and Yuxin Chen and Bei Jia and Juan Xia and Yali Xiong and Zhaoping Zhang and Weimao Ding and Rui Huang and Chao Wu},
  title = {{The Easy Liver Fibrosis Test (eLIFT) for predicting advanced liver fibrosis in patients with chronic hepatitis B.}},
  booktitle = {PubMed},
  year = {2019},
}

Loading related content...

Figure